Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04481c68d907208b086a245a70cf0708 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-74 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-74 |
filingDate |
2001-06-26^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-06-25^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5be99a446428b4316f7bb9bc82bda8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a83ab3b6d0ac56b6601c6f38e034be85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9daf2e7b7bf50cc5536a70adeded6e98 |
publicationDate |
2002-06-25^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6410545-B2 |
titleOfInvention |
Lipid lowering quinazoline dietary supplement composition |
abstract |
A novel carbonyl-substituted quinazoline, preferably 4-(3′-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), and methods for lowering blood cholesterol, including reducing total cholesterol and LDL-cholesterol levels by administration of the carbonyl quinazolines and compositions thereof. |
priorityDate |
1998-07-30^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |